Transaction · 0001213900-26-052436

Grawey Nathaniel A.

Grawey Nathaniel A., CCO, reported a transaction classified as grant at Tenon Medical, Inc. involving 68201.000000 shares for an estimated $0.00. Reported holdings after the transaction were 243584.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACCO
TNONTenon Medical, Inc.
Estimated value$0Shares × reported price
Shares traded68.2k$0.00 per share
Holdings after243kIndirect · By SiVantage, Inc.
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TNON price since this filing

Daily closing prices, with the filing date and available return windows
TNON · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -10.3%1w ago1d ago
Returns since7d30d -14.1%90d -75.6%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001213900-26-052436
Common stock
Transaction date
May 01, 2026
Filed May 05, 2026, 11:42 PM · 4d delay
Shares
68,201 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
243,584 sh
Indirect · By SiVantage, Inc.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Increase
Filing-only score

-22 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Commercial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and bet…

Original filing · 0001213900-26-052436
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TNON